ECOR
ECOR area of valueECOR has been an interesting stock, with what looks like massive pumps regularly on a declining stock. Although momentum was reversed recently, we can expect this stock to drop further down to around $1.48, at which point it will hit this area of resistance. The last couple times ECOR accumulated on this line, it has spiked up 500%, and 350%. Worth a shot with a stoploss.
As far as Insider Trading, nothing to report, at least nothing really being sold. Large amounts of shares bought by insiders in 2018 and they seemed to have held onto them.
Analysts are targeting this stock with Buy ratings and a few Hold ratings, even 2 strong buys. Average Target for 12 Mo is $4.30, the high is $8.00 and the low is $1.78
$ECOR, $ASM and $GNUSNASDAQ:ECOR
Whats going on everybody...
This video is going to be AGAIN, very different... I'm learning/discovering watching other mentors as I go. I noticed some interesting things but doesn't mean its 100% right either.
I notice that certain things REPEATS itself as well. Its tricks that some people don't want others to know/expose OR you'd have to pay for knowledge and invest in but THANK GOD for some FREE KNOWLEDGE.
Keep Grinding!!
#InvestSmart
#TRADESAFE AMEX:ASM
Electrocore Inc $ECOR (5th IDEA)WHATS GOING ON FOLKS....
Back with it but this time a update!!! lol
Been a little busy friday and monday so I figure today since I had a day off, I might as well chat some good stuff about the company's bounce back today..
Very Proud
#TradeSfae
#InvestSmart
NASDAQ:ECOR
ECOR - Bullish In Force - Possible 20% Move Due.electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
SHORT INTEREST
1.47M 08/15/19
P/E Current
-1.87
P/E Ratio (with extraordinary items)
-1.20
Average Recommendation: OVERWEIGHT
Average Target Price: 10.50